Niva Bupa Health Insurance shares climb over 13% as Q4 profit rises 31%, gross premiums surges 18%; check key details

The stock rose 13.39% to ₹91.88 per unit on the National Stock Exchange (NSE) at 9:40 am.

Niva Bupa Health Insurance Company recorded a 31.2% increase in its standalone profit after tax (PAT) to ₹206.08 crore for the fourth quarter ending March 31, 2025.

The company reported a post-tax profit of ₹157.06 crore in the corresponding period of the previous fiscal year.

In Q4 FY25, Niva Bupa posted a gross written premium (GWP) of ₹2,078.65 crore, reflecting a year-on-year growth of 18.14% from ₹1,759.44 crore in the year-ago period.

Net written premium advanced 20.99% to ₹1,672.11 crore in the latest January-March quarter, compared to ₹1,381.92 crore a year back.

In an exchange filing, the company said it increased its retail health market share to 9.4% in FY25 from 9.1% in FY24, strengthening its position among key players in the Indian health insurance sector.

Krishnan Ramachandran, MD & CEO, Niva Bupa, said, "We are proud of the strong performance we have delivered this year, both in terms of top-line growth and customer service excellence. This growth is a testament to the trust customers place in us and our ability to deliver consistent value. With a strong foundation and strategic vision, Niva Bupa is well-positioned to capitalise on the growing demand for health insurance in India and continue its journey of high-impact growth and innovation."

As of March 2025, the company has more than 212 physical branches across the country and offers health insurance via a network of over 180,000 agents, 540 brokers and 100 Banca & other corporate agency partners.

It has an employee base of over 8,900 people.